Continuous anticoagulation may effectively reduce the incidence of thromboembolic events in patients with orthopedic trauma, ...

PONTE VEDRA, FL / ACCESS Newswire / December 29, 2025 / Every industry has its forgotten corners. In anticoagulation, those ...

"Patients with cancer-associated thrombosis are both at risk of recurrent venous thromboembolism and bleeding during extended anticoagulant," said Mahé in a recorded talk of her ASH poster ...

PONTE VEDRA, FL / / December 30, 2025 / Some companies enter a market because they see opportunity. Others step in because ...

Atrial fibrillation (AF), which affects approximately 3-6 million people in the United States, is a risk factor for thromboembolic events including stroke, cardiovascular events, and death. This ...

The roles of anticoagulation alone or with an antiplatelet agent after transcatheter aortic-valve implantation (TAVI) have not been well studied. We performed a randomized trial of clopidogrel in ...

A series of neutral trials on anticoagulation in embolic stroke of undetermined source (ESUS) has moved the needle scientifically but left physicians with questions about secondary prevention and the ...

SAN FRANCISCO, CA—Oral anticoagulation following transcatheter aortic valve replacement fails to lower the incidence of new subclinical cerebral lesions identified on imaging when compared with dual ...

Detailed price information for Cadrenal Therapeutics Inc (CVKD-Q) from The Globe and Mail including charting and trades.